This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard D. Moore, MD; Jeanne C. Keruly; Richard E. Chaisson, MD

Arch Intern Med. 1995;155(18):1965-1970.

Abstract
Background
In human immunodeficiency virus (HIV) disease, neutropenia occurs most commonly in patients who are also severely immunosuppressed. It is not currently known whether neutropenia is an independent risk factor for the development of bacterial infection, which is a potentially serious complication of advanced HIV disease.

Methods
We compared the incidence of bacterial infection between 118 neutropenic patients (absolute neutrophil count [ANC], <1x10⁹/L) and 118 nonneutropenic patients matched for CD4⁺ lymphocyte count, use of injecting drugs, and follow-up time from a demographically heterogeneous urban cohort of HIV-infected patients followed up longitudinally at the Johns Hopkins Hospital. The incidence of serious infection was analyzed separately for patients with an ANC of less than 1, less than 0.75, or less than 0.5x10⁹/L.

Results
There were no statistically significant associations found between neutropenia and several individual bacterial infections, including bacteremia, pneumonia, endocarditis, bacterial enterocolitis, and infection of normally sterile sites for any level of neutropenia. However, for all these infections combined, the adjusted relative risk for the occurrence of bacterial infection was 2.33 (95% confidence interval, 1.00 to 5.40; P=.05) for patients with an ANC of less than 1x10⁹/L and 7.92 (95% confidence interval, 1.18 to 53.2; P=.03) for those with an ANC of less than 0.5x10⁹/L. The incidence of serious bacterial infection ranged from two to three infections per 100 person-months of neutropenia for patients with an ANC of less than 1x10⁹/L and three to five infections per 100 person-months of neutropenia for patients with an ANC of less than 0.5x10⁹/L for all bacterial infections combined.

Conclusions
Our matched cohort analysis indicates that neutropenia is an independent risk factor for bacterial infection in patients with advanced HIV disease. Given the incidence of infection, the cost-effectiveness of interventions to prevent neutropenia in advanced HIV disease should be assessed.

(Arch Intern Med. 1995;155:1965-1970)

Author Affiliations
From The Johns Hopkins University School of Medicine, Baltimore, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neutropenia in Human Immunodeficiency Virus Infection: Data From the Women's Interagency HIV Study.
Levine et al.
Arch Intern Med 2006;166:405-410.
ABSTRACT | FULL TEXT  

Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients
Mayaud et al.
Eur Respir J 2002;20:28S-39s.
ABSTRACT | FULL TEXT  

Soluble CD16 Inhibits CR3 (CD11b/CD18)-Mediated Infection of Monocytes/Macrophages by Opsonized Primary R5 HIV-1
Bouhlal et al.
J. Immunol. 2001;166:3377-3383.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus Disease-Related Neutropenia and the Risk of Hospitalization for Bacterial Infection
Jacobson et al.
Arch Intern Med 1997;157:1825-1831.
ABSTRACT  

Neutropenia and latrogenic Neutrophil Dysfunction in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
Arnott et al.
Arch Intern Med 1996;156:1475-1476.
ABSTRACT  

Neutropenia Independently Linked to Bacterial Infection
AIDS Clin Care 1995;1995:7-7.
FULL TEXT